Understanding the Global Transmission and Demographic Distribution of Nipah Virus (NiV)

Author:

Ahmed Mahedi Md. Rezwan1,Rawat Anurag2,Rabbi Fazle3,Babu K. Suresh4,Tasayco Elias SALVADOR5,Ore Areche Franklin6,Pacovilca-Alejo Olga Vicentina7,Corilla Flores Denis Dante7,Vivanco Aguilar Salomón7,L. Orosco Fredmoore8,Syrmos Nikolaos9,Mudhafar Mustafa10,Afrin Sadia1,Rahman Mst. Mahfuza11

Affiliation:

1. Department of Pharmacy, Comilla University.

2. Associate Professor, Cardiology Himalayan Institute of Medical Science Jolly Grant Dehradun 248140 Uttaranchal India.

3. Australian Computer Society.

4. Professor, Department of Biochemistry, Symbiosis Medical College for Women, Symbiosis International (Deemed University), Pune.

5. Universidad Nacional "San Luis Gonzaga" – Peru.

6. National University of Huancavelica, Huancavelica – Peru. 7Industrial Technology Development Institute, Department of Science and Technology, Taguig City, Philippines.

7. National University of Huancavelica, Huancavelica – Peru.

8. Industrial Technology Development Institute, Department of Science and Technology, Taguig City, Philippines.

9. Human Performance and Health, Aristotle University of Thessaloniki, Thesaaloniki, Macedonia, Greece.

10. Department of Pharmaceutical Chemistry, College of Pharmacy, University of Ahl Al Bayt, 56001, Karbala, Iraq.

11. Assistant Professor, Department of Pharmacy, Comilla University, Bangladesh.

Abstract

Nipah virus (NIV) infection was identified in 1998, in Malaysia. The virus belongs to the Paramyxoviridae family. In the past, the virus was spread in Bangladesh, India, as well as Singapore. It affects our nervous system and the respiratory system, which is highly dangerous for our lives. It is caused by an RNA virus and has a high mortality rate. This virus can be transmitted from bats to humans, pigs to humans, or humans to humans. It is conceptualized that fruit bats like Pteropus vampyrus and Pteropus hypomelanus are responsible for transmitting the virus. From 1999 to 2022, there is no approved vaccine and medicines for the treatment of nipah virus infection. The fatality rate of this nipah virus is 75% to 95%. Moreover, NiV B (Bangladesh) is more deathly than NiV M (Malaysia). In present, some vaccines are under trial on pigs, horses and the monkey. In this review we try to focus on the barrier of vaccine and medicine development for this nipah virus.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3